Annual report 2023

Proposal of the Board of Directors for the appropriation of the available profit

in CHF

 

2023

 

2022

Profit / (loss) for the year

 

33’551’684

 

14’269’773

Unallocated profit carried forward from previous year

 

2’861’343

 

4’045’272

Total available profit

 

36’413’027

 

18’315’045

Appropriation from voluntary retained earnings

 

 

5’000’000

Ordinary dividend

 

–20’390’924

 

–20’453’702

Balance carried forward

 

16’022’104

 

2’861’343

 

 

 

 

 

Dividend distribution per share

 

 

 

 

Gross dividend

 

0.50

 

0.50

Withholding tax (35%)

 

–0.18

 

–0.18

Net dividend

 

0.32

 

0.32

The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 24, 2024. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.